Feasibility and acceptability of an adapted environmental enrichment intervention for endometriosis: A pilot study

Introduction

Environmental enrichment (EE) is defined as a “combination of inanimate and social stimulation” involving a socially integrated lifestyle, physical and cognitive stimulation, and larger spaces (1–4). In animal models, EE improves cognition and memory, symptomatology of stroke, Alzheimer's disease (AD), Huntington's disease, chronic stress, visceral/inflammatory pain, depression, and anxiety (5–17). A translated EE intervention was recently shown to increase physical, social, and cognitive levels in acute stroke patients and to decrease adverse events compared to the standard of care counterparts (18–21). A recent study associated levels of EE exposure with depressive symptoms through an EE indicator that measured cognitive, social, and physical activity and could differentiate participants with major depression from control subjects (22). Still, very few studies of multi-modal interventions involving features of EE have been conducted in humans, and none in pain or inflammatory disorders.

The mechanisms by which EE provides its benefits are hypothesized to be at multiple levels, with strong evidence showing modulation of immune pathways to produce anti-inflammatory effects (23, 24), as well as at the central level through increased expression of brain-derived neurotrophic factor (BDNF) and decreased levels of corticotropin-releasing factor receptor type 1 (CRFR1) in amygdala (6, 16). In addition, EE causes “eustress”, the type of stressor that provides hope and a feeling of fulfillment (e.g., a new opportunity linked to a positive outcome) (25, 26). Eustress positively affects the quality of life (QoL), psychological coping, and mental health, increased level of resiliency to challenges. Independently, features of EE—large spaces for therapy, use of multi-sensorial equipment, active engagement in novel activities, and enhanced social interactions—have been used in the clinic (27, 28). However, despite ample evidence of EE effectiveness in animal models and the encouraging results in patients with stroke, there is still an unmet need to adapt the EE paradigm to the human scenario and generate outcomes on its clinical efficacy for stress-related and inflammatory disorders.

The painful symptoms of endometriosis—severe dysmenorrhea, dyspareunia, and chronic pelvic pain—lead to high stress due to their negative impact on psychological wellbeing, social functioning, and QoL (29–31). Stress alters gut and uterus motility, exacerbates inflammatory parameters, and is known to increase visceral pain perception (10, 32–35). We and others have shown that women with endometriosis or dysmenorrhea have low levels of cortisol compared to controls (36–38). Moreover, cortisol levels were negatively correlated with symptoms (dyspareunia, infertility) in patients who also showed elevated anxiety state scores (38). Therefore, it has been suggested that stress management could improve endometriosis symptomatology and general wellbeing of endometriosis patients. Our group conducted animal studies showing for the first time the contribution of stress to the development and progression of endometriosis (34, 35, 39). Stress increased vesicle size and number, colonic inflammation and motility, inflammatory cell infiltration into vesicles, expression of nerve growth factor (NGF) and its receptors in uterus. It also deregulated hypothalamic-pituitary-adrenal (HPA) axis responses in rats with endometriosis. Importantly, we showed that the ability to control the stress reversed these parameters resulting in smaller vesicles and decreased cellular infiltration and inflammation (40).

Together, our research using the rat model of endometriosis suggest that while stress contributes to disease development and severity in the rat model through mechanisms involving inflammation, nerve growth, and HPA axis deregulation, stress controllability improves disease progression, thus offering possibilities for therapeutic interventions based on this paradigm (41). Given these promising results, we hypothesized that EE would stabilize HPA axis activity and reduce lesion development in a rat model of endometriosis. We found that in rats with experimental endometriosis exposed to EE, the number and size of developed endometriotic vesicles were significantly decreased compared to those under control conditions (42). In addition, rats in the EE group spent more time in the center of an open field box, suggesting decreased unconditioned anxiety behaviors. These results strongly suggest that the combination of elements in EE could also have beneficial effects by reducing stress while improving mental health and disease severity in the clinical scenario.

To address this question, we proposed to adapt and test a multi-level structured program based on the EE paradigm for endometriosis patients. Using an integrative, patient-centered methodology, we developed an EE intervention program consisting of six modules, with activities mimicking and integrating the three hallmarks of EE: social support, novelty, and open spaces. Here, we describe the acceptability and feasibility of a novel, translated EE intervention to be used as an adjuvant to standard care in women with endometriosis, an inflammatory, painful disease associated with chronic stress. Future analysis of efficacy data collected from this randomized clinical trial (RCT) will assess whether EE promotes stress management, immune modulation, pain relief, and improvements in mental health and QoL for women with endometriosis.

Methods

Translation of the EE intervention

A team composed of investigators with expertise in psychology, physiology, neuroscience, integrative mind-body, gynecology, translational research, and stress management, met for a year to translate the environmental enrichment (EE) paradigm that was proven efficacious in the rat model to the clinical setting. A pilot RCT was designed to test (1) acceptability and feasibility of the intervention and (2) EE's efficacy for reducing painful symptoms and improving QoL. The adaptation followed the ORBIT Model for developing behavioral interventions for chronic diseases (43). This model guides the early pre-efficacy stages of behavioral intervention development using a four-phase approach (F1: design, F2: preliminary efficacy, F3: efficacy, F4: effectiveness. Guided by the model, we translated a basic neurobehavioral finding (EE reduces the growth of lesions in rats) into a clinical question (will an EE intervention effectively reduce pain symptoms/inflammation and increase QoL in endometriosis?). First, we conducted a systematic literature review to select the approaches for the adapted EE intervention, using the PRISMA-P 2015 protocol and the PRISMA evaluation checklist (44, 45). Through this process, we identified treatment components to reflect the three hallmarks of the EE paradigm (social support, novelty, open spaces) that were tested in RCTs for pain, inflammation, or chronic disorders: yoga, yogic breathing, mindfulness, aromatherapy, art therapy, music and drama therapy, support groups and the outdoors (46–59). Decisions on the interventions to be included in the final program were based on the following factors: (1) evidence that the activity was effective for improving symptomatology and QoL, even if had not been tested in endometriosis, (2) local availability of certified coaches, (3) time limitations (up to 3 h), and (4) involving gentle physical activity. A team composed of the PI, Research Coordinator, and Wellness expert scouted potential venues to identify those with open spaces overlooking natural areas and located within an hour's drive from Ponce. The Patient Advisory Committee (PAC), composed of five members of the Fundación Puertorriqueña de Pacientes con Endometriosis (ENDOPR), a patient support foundation in Puerto Rico, evaluated the proposed activities (no concerns), venues (all approved), preference of date/time (Thursday PM or Saturday AM), frequency (every two weeks) and duration (3 h) of the EE modules.

Recruitment

After IRB approval (Protocol #1901004205R003), we conducted a recruitment campaign using social media (Facebook, Instagram, Twitter) of ENDOPR. Recruitment for Session I took place from September 2019 to December 2021. We had to delay the start of the RCT due to a series of earthquakes (January–February 2020) and the COVID-19 pandemic (March 2020). A second recruitment campaign was conducted from February to June 2021. Recruitment for Session II took place from August 2021 to February 2022. Patients interested in participating were screened for inclusion/exclusion criteria and consented prior to randomization into the intervention or control groups.

Inclusion and exclusion criteria

Participants were women with a surgical diagnosis of endometriosis, 18–50 years old, symptomatic (currently experiencing pelvic pain despite treatment), who could commit the time to participate in EE intervention for three months. We excluded patients who were pregnant or planning to become pregnant during the study period; post-menopausal; with documented impairments that would interfere with participation or consent; under psychiatry treatment; using steroid medications. We also excluded those affected by other confounding conditions, including pain syndromes (e.g., fibromyalgia, chronic fatigue syndrome, arthritis).

Study design of the pilot RCT

To evaluate the feasibility, acceptability, and efficacy of a translated EE intervention for endometriosis patients, we conducted a RCT of parallel design with an attention control group (standard of care plus educational webinar) and an intervention group (EE intervention) from August 2021 to July 2022. Participants completed surveys to assess: (1) clinical history (Endometriosis Phenome Project Clinical Questionnaire -EPhect-Q) (60), (2) QoL (Endometriosis Health Profile-30, EHP-30), (3) pelvic pain (Brief Pain Inventory, BPI), (4) perceived stress (Perceived Stress Scale-14, PSS-14), (5) co-morbidities, and (6) mental health symptomatology (General Anxiety Disorder-7, GAD7, and Patient Health Questionnaire-8, PHQ-8). Biospecimens (saliva for cortisol, serum for inflammatory cytokines) were collected at baseline, end of the intervention (6 modules), and three months after the end of the intervention. We conducted group assignments by computer-generated permuted block randomization. Subjects randomized to the intervention condition received the EE intervention as an adjuvant to standard gynecological care consisting of hormonal, analgesic, or surgical treatment. Participants randomized to the control condition received standard gynecological care and were invited to participate in an online seminar about endometriosis (“Becoming an Endometriosis Patient Expert” delivered by the PI). For ethical reasons, patients allocated to the controlled group were offered the EE intervention after completing the follow-up assessments. We collected samples (blood, saliva) and study surveys from subjects in the control group during home visits. For this group, we also assessed feasibility. Primary and secondary outcomes of the EE intervention—pain and QoL improvement, mental health (depression and anxiety), and stress improvements, as well as correlations with cortisol changes and inflammatory markers—will be assessed in ongoing efficacy studies.

Study subject demographics

Sociodemographic and clinical data obtained from subjects in the intervention and control groups through the Endometriosis Phenome Project (EPHect) questionnaire were analyzed using descriptive statistics (means, %, frequency, proportions).

Feasibility measures

We evaluated the feasibility of the EE intervention at three levels: recruitment, enrollment, and adherence to treatment. For all metrics, we defined feasibility as Definitely, Possibly, or Not feasible (>70%, 50%–69%, or <50% of eligible participants recruited, respectively). Recruitment feasibility was the ratio of the number of subjects who met the inclusion criteria and the number of eligible subjects. Enrollment feasibility is the proportion of eligible patients who agreed to participate in the study. Adherence to treatment and retention were monitored by keeping a record of dropouts, loss to follow-up, attendance to sessions, completion of surveys, and completion of the intervention (six modules). The reasons for missing sessions or dropping out were recorded.

Acceptability measures

We assessed participants' satisfaction three months after the end of the intervention with a survey and during focus group meetings. Participants assessed the EE intervention logistics and delivery process, including the day/time, location, and frequency of meetings.

Qualitative data analysis

During the post-intervention focus group meetings, group facilitators asked subjects to evaluate their perceived value of the EE intervention. All audio transcripts were transcribed and verified by advanced psychology students. A thematic analysis was conducted to interpret the transcripts from the follow-up sessions and the open-ended questions of the evaluation survey. This technique allows the researcher to identify, analyze and report the themes that emerge from the recollected data. To achieve this, the Braun & Clark (2021) (61) six-phase conceptual framework was used. From this approach, the thematic analysis process focuses on the relevance and importance of the identified themes and how they relate to the objective of the study. In this study, the relevant themes were associated with the feedback provided by the participants based on their experience during the environmental enrichment interventions and the support groups. Two advanced psychology students transcribed verbatim and checked for accuracy to minimize bias. Then, three research team members read the transcripts and independently identified initial categories. Finally, the team discussed and identified the final categories. After being 100% in agreement, the final themes and sub-categories were selected and NVivo 12 software was used to systematically organize the data using specific verbatims.

Results

Development of the EE intervention modules

We developed six EE modules, integrating knowledge from a literature review, expert opinion, and input from the PAC. Each module reflected the three hallmarks of the EE paradigm: social support, novelty, and open spaces. The PAC evaluated and approved the proposed activities, venues, date/time, frequency, and duration of the EE modules. They considered that the intervention addressed the needs, concerns, and expectations regarding complementary approaches for endometriosis symptom management. The final intervention consisted of six modules administered every other Saturday morning that included: a support group meeting (1 ½ h) and a novel stress-management activity (1 h) that took place in open space venues: beach, lake, garden, hot springs, countryside (Figure 1). For the final program, the team selected the following activities: yoga, yogic breathing, mindfulness with aromatherapy, art therapy, drama therapy, and dance therapy.

FIGURE 1

Figure 1. Translation of the EE paradigm to humans. A multidisciplinary team of experts, with input from a patient advisory committee, translated an enriched environment intervention based on the EE paradigm consisting of social support, novelty, and open spaces to be tested in a pilot psychosocial trial. EE interventions took place in open space venues (e.g., beach, lake, garden, hot springs, countryside) and consisted of a support group meeting (1 ½ h) and a novel stress-management activity (1 h). The interventions were conducted every other Saturday morning for a period of 6 months.

Recruitment, enrollment, and retention

The RCT was conducted in two sessions over 8 months (August 2021–April 2022). Overall, of 118 individuals responding to the study advertisements, 103 (85 + 18 waitlist controls) were randomized into the intervention (n = 64) and control (n = 39) groups for an exclusion rate of 28.0%. Dropouts (including those excused, no-shows, and those not completing the consent form) were 35 (54.7%) in the intervention group and 12 (30.8%) in the control group. The final enrollment was 29 subjects in the intervention and 27 in the control groups, and adherence rates (subjects who completed the six interventions) were 41.4% and 100%, respectively (Figure 2, Table 1).

FIGURE 2

Figure 2. Enrollment diagram. The recruitment, enrollment, and retention of the EE pilot RCT are shown. Recruitment was conducted via social media of a patient support foundation. There were two recruitment efforts for Session I which took place from August to October 2021, and one for Session II which took place February to April 2022. A total of 118 individuals were screened and 103 were randomized to the EE vs. control groups. Final enrollment was n = 29 (EE) and n = 27 (control). Dropout rates were 54.7% for the EE group and 30.8% for the control group.

TABLE 1

Table 1. Recruitment, enrollment, and retention of the EE intervention.

For the first session, a total of 54 individuals responded to our initial advertisement from August 2019 to December 2019; 38 met the inclusion criteria (70.4%) and were randomized into the intervention (n = 21) and control (n = 17) groups. The intervention was planned to start on January 11th, 2020. Unfortunately, Puerto Rico suffered a series of earthquakes starting on January 7th that forced the postponing of the intervention. On March 2020, Puerto Rico entered a lockdown mandated by the government due to COVID-19, forcing a second postponing of the intervention. These delays led to dropouts (n = 21, 55.3%) for reasons including pregnancy, relocation, and work/study issues. A second recruitment effort was conducted from February 2021 to July 2021, in which 26 individuals contacted our program; 17 met inclusion criteria (65.4%) and were randomized to the intervention (n = 9) and control (n = 8) groups. There were two other dropouts after the intervention started. Overall, for Session I, 80 individuals contacted our program, and 55 (68.8%) were randomized to the intervention (n = 30) and control (n = 25) groups. Dropout rates for Session I were 53.3% (n = 16) and 28.0% (n = 7) in the intervention and control groups, respectively. The final study groups were 14 subjects in the intervention group and 18 in the control group for Session I (August to October 2021).

For Session II, a third recruitment session took place from August 2021 to February 2022. Of the 38 individuals responding to the study advertisements, 30 (79.2%) met the inclusion criteria and were randomized to the intervention (n = 16) and control (n = 14) groups. The attention control group from Session I (n = 18) was invited to participate in the Session II intervention, for a total of 34 subjects randomized to the intervention group. Dropout rates for Session II were 55.9% (n = 19) in the intervention group and 35.7% (n = 5) in the control group for reasons including work/study, distance to intervention locations, or lost to follow-up. No subjects dropped out during Session II. The final study groups were 15 subjects in the intervention group and 9 in the control group for Session II (February to April 2022).

Study subject characteristics

The clinic-demographic data from subjects in the study groups are shown in Table 2. No significant differences were observed between the study groups, except for the proportion of subjects with post-graduate education. Baseline mean levels of current pelvic pain measured by the Brief Pain Inventory (BPI) were 8.0 (SD ± 2.2) and 6.4 (SD ± 3.3) for the intervention and control groups, which was not significantly different. Baseline perceived stress levels measured by the Perceived Stress Scale 14 (PSS-14) were 32.5 (SD ± 5.7) and 28.0 (SD ± 4.4) for the intervention and control groups, which was not significantly different.

TABLE 2

Table 2. Clinic-demographic characteristics of the study population.

Feasibility measures

Table 3 summarizes the metrics of feasibility: recruitment success (how many qualified and were randomized), enrollment rates (how many started the intervention), and adherence rates (how many completed the intervention), for each of the study groups.

TABLE 3

Table 3. Feasibility results.

Acceptability measures

We evaluated participation rate, completion rates of the study surveys per intervention (baseline, mid-term, end, 3-month follow-up), and acceptability of the intervention using a post-intervention evaluation survey and focus group.

Participation rate

A total of 12 subjects in the EE group completed all six interventions (full dose) (41.4%), and 17 participants completed at least three interventions (half dose) (58.6%) (Figure 3A). The most common reasons for missing an intervention were period pain (39.1%; n = 9), work-study (34.8%, n = 8), and family commitment conflicts (30.4%, n = 7) (Figure 3B).

FIGURE 3

Figure 3. Participation rate of study subjects in the EE intervention. Full dose and half dose are shown in panel A. Reasons for missing an intervention were documented via an online survey are shown in panel B.

Survey completion rates

Table 4 summarizes the survey completion rate by study group. In general, we observed high response rates for all surveys (>80%) except for the 3-month follow-up after the end of the intervention time point.

TABLE 4

Table 4. Survey completion rates.

Intervention evaluation survey

Subjects allocated to the EE group (n = 29) were sent an electronic link to a post-intervention survey. The favorite module was yoga (83.3%, n = 20) (Figure 4A); the favorite location was the Japanese garden (78.3%, n = 18) (Figure 4B). Figure 4C shows the acceptability of the study logistics ranging from 95.7% (n = 22) for the intervention day (Saturday) to 69.6% (n = 16) for the frequency (every two weeks). The support group component of the intervention was evaluated as Excellent by 90.5% (n = 19/21). When asked if they would recommend the EE intervention to other patients 95.7% (n = 22/23) of them said Yes. When asked about desire to have future participation in support groups with other women with endometriosis 82.4% (n = 28/34) said they would participate regularly (this included subjects who were randomized to the intervention but did not participate). Salient verbatims of the answers to an open question on the survey (Any comments on the support group experience?) are included in Table 5.

FIGURE 4

Figure 4. Intervention evaluation survey results are shown. Favorite modules are shown in panel A. Favorite venues are shown in panel B. Acceptability of logistics are shown in panel C.

TABLE 5

Table 5. Feasibility of the EE intervention: analysis of open-ended question answers in the final evaluation survey.

Exit interview evaluation focus groups

During the 3-month follow-up session, 12 patients from the intervention group only participated in focus group discussions to gather qualitative data regarding their acceptability and perceived value of the EE intervention. Qualitative analysis of the exit focus group transcriptions using NVivo-12 is shown in Figure 5 and Table 6. Perceived relative importance is reflected in the font size. The most beneficial aspect of the intervention was the perceived improvement of endometriosis symptoms. The themes identified were accompaniment, consciousness, responsibility, and understanding. “Not feeling alone” was one of the aspects they valued the most from the accompaniment theme. Effects of EE on the management of their condition were categorized in these themes: validating, effective, soothing, critical, accessible, functional, and valuable, which evidence a high acceptability of the interventions.

FIGURE 5

Figure 5. Word clouds representing the most common words used to describe the subjects’ experience during the EE intervention. Transcripts from support group discussion that took place 3 months after the end of the intervention were analyzed using NVivo. Perceived benefits of the EE intervention are shown in panel A. Perceived value of the EE intervention for the management of endometriosis symptoms is shown in panel B.

TABLE 6

Table 6. Feasibility of the EE intervention: analysis of 3-month after the end of the intervention group discussion transcripts.

RCT safety

During the two sessions of the EE intervention there were no severe adverse events (SAE), and no patient had to stop treatment due to an adverse event (AE). Only one AE was reported during the aromatherapy intervention: a mild and transient irritation to an essential oil.

Discussion

Here we report the acceptability and feasibility results of the first clinical study of an enriched environment intervention providing social support, novelty, and open spaces in patients with endometriosis. Based on our previous findings that EE can effectively reduce disease progression and anxiety behaviors in a rat model (42), our multidisciplinary team developed an integrative multi-modal intervention based on this psychosocial paradigm. Through this pilot RCT, we demonstrated that the adapted EE intervention is acceptable as an adjuvant to standard care for endometriosis. However, feasibility results, shown by enrollment and adherence rates, indicate that additional refinement would be needed to facilitate its implementation. Data from this study and follow-up studies on efficacy involving a larger sample size will inform the implementation of mind-body integrative medicine strategies in the standard of care for this painful and challenging condition.

Our team was the first to experimentally demonstrate that stress increases the size of endometriosis lesions and worsens inflammation and anxiety (34, 35). We also showed that the “controllability” of stress can influence endometriosis pathophysiology, offering the possibility of using stress management and coping techniques as complementary approaches in patients with this condition (40). Other investigators have also shown the beneficial effects of stress management and EE on other rodent models of endometriosis (62). Supported by our landmark observations, it has been suggested that dysregulations in the HPA axis caused by chronic pain may lead to activating pro-inflammatory mechanisms, directly impacting mental health and, potentially, lesion growth. Therefore, our well-controlled studies in the animal model, together with the clinical literature, suggest that targeting the HPA using stress relief should alleviate inflammation and alter responses to pain. These data support the unique opportunity of altering brain-body-brain pathways as potential complementary and interdisciplinary therapeutic options for endometriosis (29).

Prior research in the field of complementary and integrative medicine has shown that stress-coping strategies (yoga, tai-chi, support groups) have beneficial effects on chronic pain conditions, inflammation, immune and brain function, as well as anxiety, depression, and stress levels (63–67). Disease processes exacerbated by stress can be interrupted by psychological and stress reduction interventions, including social coping, psychotherapy, exercise, relaxation, meditation, and yoga (68–70). Because chronic pelvic pain, a hallmark of endometriosis, is associated with multiple factors (social, biological, psychological), its clinical management is challenging. Many patients remain in pain despite multiple interventions involving hormonal therapies and surgery. Despite strong evidence that women with endometriosis have a high prevalence of substantial stress levels and of a strong association between stress and disease severity (29), there has been limited investigation regarding integrative medicine alternatives for endometriosis, with few published RCTs (46, 59, 71–73). As a result, patients are still at a loss concerning alternative options for managing symptoms as well as their impact on emotional wellbeing and mental health when conventional therapies fail or provide only partial, short-term relief.

To provide patients with alternative non-pharmacological, non-surgical adjuvant treatment approaches for managing endometriosis-associated pain and mental health disturbances, our team used a mixed methods approach for translating the EE paradigm into a pilot integrative multi-modal intervention. We showed that the intervention was feasible based on the total number of patients who met the inclusion criteria and were randomized. The enrollment rate was low due to the various challenges we had to tackle during the study. First, we had to postpone the start of the intervention due to earthquakes (January-February 2020) and then the COVID-19 lockdowns and restrictions (March 2020-March 2021). After a one-year hiatus, the study started in August of 2021 when the restrictions for gatherings were suspended, and vaccination and treatments were available. However, this delay meant that we had to re-start our recruitment campaign for the first intervention session. Of note, both EE sessions were conducted during the COVID-19 pandemic (August 2021-February 2022), which must be considered when analyzing the results. However, none of the subjects identified the pandemic as a reason for not participating or missing an intervention.

Adherence rate was lower for the intervention group than the control group. This was expected as the intervention involved traveling to different venues and a commitment of four hrs on six alternating Saturday mornings, while controls were visited in their homes or meeting points for sample and survey collection and had a minimal time commitment (∼30 min). The most common reason for missing an intervention was pelvic pain, which in patients with endometriosis is unpredictable and incapacitating, followed by work/study issues. Though some patients needed to travel to distant locations (30 min–1 h) during the study, most enrolled participants did not consider this an inconvenience. However, this was a factor impeding participation for some of the screened potential participants. Future interventions should consider the distance to venues to overcome participation limitations due to transportation issues. There was a dropout rate of 30% in the control group which can be ascribed to the natural emergencies experienced during the study. Participation rates were 58.6% for at least a half dose (≥3 interventions or more) and 41.4% for the full dose. In future interventions, make-up sessions could be offered to solve attendance issues due to pain or work/family conflicts.

Despite the low enrollment and adherence rates observed in the intervention group, the intervention was highly acceptable (>70%–96% positive evaluation of the logistics) and perceived as valuable by participants, according to both quantitative data (post-intervention evaluation and qualitative data at 3-month follow-up focus group). Survey completion rates were very high (>80%) throughout the intervention timeframe but dropped substantially 3-months post-intervention. The support group component of the intervention was perceived as Excellent by 91%, and 82.4% said they would participate regularly. Most participants (96%) said they would recommend the intervention to other patients. Although there are other available support systems for women with endometriosis such as online groups and chats, the structured nature of the EE intervention may have played a role in the high acceptability rates shown by this RCT.

To our knowledge, translation of the EE paradigm to clinical use in pain/inflammatory disorders has not been undertaken, despite ample evidence from animal models alluding to its anti-stress and anti-inflammatory effects. Others have commented on the challenges of translating this multi-modal systematic approach consisting of psychological (group support), behavioral (novelty), and stress-reduction (open environments) to the human scenario (74). In our experience, the major challenges to implementing the EE intervention included unpredictable events that impacted enrollment (e.g., the COVID-19 pandemic) and conflicts due to work/study that impaired participation. Effective delivery of the EE program would require significant human resources, which we solved by leveraging advanced graduate (MD, PsyD, MPH, nursing) students in our institution. An MoP with detailed step-by-step protocols and videos will be available to psychology professionals to enable the intervention to be replicated similarly, regardless of location. This pilot RCT demonstrated high acceptability of patients of this multi-modal integrative medicine approach and uncovered challenges and opportunities for improvement to ensure feasibility. Additional studies in a diverse patient population are warranted to ensure the generalizability of its findings. Future analysis of the efficacy data collected during this study will assess whether this intervention produces significant positive outcomes in endometriosis patients regarding pain and stress perception, mental health, and QoL.

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

The studies involving human participants were reviewed and approved by Ponce Research Institute (PRI) Institutional Review Board. The patients/participants provided their written informed consent to participate in this study.

Author contributions

All authors made substantial contributions to the study, drafted the manuscript or revised it critically, and approved the version to be published. All authors agree to be accountable for all aspects of the work, its accuracy and integrity. Conception or design of the work: IF, ATR, CBA, EMC, PMR; Data acquisition: PMR, CNV, VLR, IF, ATR, CBA; Data analysis: IF, ATR, CNV, VLR, ADM, INR; Interpretation of data: IF, ATR, CBA, CNV, VLR, ALD, ADM, EMC Writing and revising manuscript: IF, ATR, CBA, CNV, ADM, ALD, VLR, EMC, PMR.

Funding

This study was funded by grant R21 HD098481 entitled Enriched environments: a multi-level integrative medicine intervention for endometriosis from the NICHD-NIH to IF.

Acknowledgment

We thank Yoan E. Rodriguez and Gabriela Guerra for their contributions to data analysis in this manuscript.

Conflict of interest

ATR, CBA, IF are co-founders of Sur180 Therapeutics, LLC.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Young J, Pionk T, Hiatt I, Geeck K, Smith JS. Environmental enrichment aides in functional recovery following unilateral controlled cortical impact of the forelimb sensorimotor area however intranasal administration of nerve growth factor does not. Brain Res Bull. (2015) 115:17-22. doi: 10.1016/j.brainresbull.2015.04.003

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Sztainberg Y, Chen A. An environmental enrichment model for mice. Nat Protoc. (2010) 5(9):1535-9. doi: 10.1038/nprot.2010.114

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Simpson J, Kelly JP. The impact of environmental enrichment in laboratory rats--behavioural and neurochemical aspects. Behav Brain Res. (2011) 222(1):246-64. doi: 10.1016/j.bbr.2011.04.002

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Hutchinson E, Avery A, Vandewoude S. Environmental enrichment for laboratory rodents. ILAR J. (2005) 46(2):148-61. doi: 10.1093/ilar.46.2.148

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Benaroya-Milshtein N, Hollander N, Apter A, Kukulansky T, Raz N, Wilf A, et al. Environmental enrichment in mice decreases anxiety, attenuates stress responses and enhances natural killer cell activity. Eur J Neurosci. (2004) 20(5):1341-7. doi: 10.1111/j.1460-9568.2004.03587.x

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Bondi CO, Klitsch KC, Leary JB, Kline AE. Environmental enrichment as a viable neurorehabilitation strategy for experimental traumatic brain injury. J Neurotrauma. (2014) 31(10):873-88. doi: 10.1089/neu.2014.3328

PubMed Abstract | CrossRef Full Text | Google Scholar

7. de la Tremblaye PB, Cheng JP, Bondi CO, Kline AE. Environmental enrichment, alone or in combination with various pharmacotherapies, confers marked benefits after traumatic brain injury. Neuropharmacology. (2019) 145(Pt A):13-24.29499273

PubMed Abstract | Google Scholar

8. Du X, Leang L, Mustafa T, Renoir T, Pang TY, Hannan AJ. Environmental enrichment rescues female-specific hyperactivity of the hypothalamic-pituitary-adrenal axis in a model of Huntington's disease. Transl Psychiatry. (2012) 2:e133. doi: 10.1038/tp.2012.58

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Gabriel AF, Marcus MA, Honig WM, Joosten EA. Preoperative housing in an enriched environment significantly reduces the duration of post-operative pain in a rat model of knee inflammation. Neurosci Lett. (2010) 469(2):219-23. doi: 10.1016/j.neulet.2009.11.078

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Gabriel AF, Paoletti G, Della Seta D, Panelli R, Marcus MA, Farabollini F, et al. Enriched environment and the recovery from inflammatory pain: Social versus physical aspects and their interaction. Behav Brain Res. (2010) 208(1):90-5.19914294

PubMed Abstract | Google Scholar

11. Goncalves LV, Herlinger AL, Ferreira TAA, Coitinho JB, Pires RGW, Martins-Silva C. Environmental enrichment cognitive neuroprotection in an experimental model of cerebral ischemia: biochemical and molecular aspects. Behav Brain Res. (2018) 348:171-83. doi: 10.1016/j.bbr.2018.04.023

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Gortz N, Lewejohann L, Tomm M, Ambree O, Keyvani K, Paulus W, et al. Effects of environmental enrichment on exploration, anxiety, and memory in female TgCRND8 Alzheimer mice. Behav Brain Res. (2008) 191(1):43-8. doi: 10.1016/j.bbr.2008.03.006

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Herring A, Blome M, Ambree O, Sachser N, Paulus W, Keyvani K. Reduction of cerebral oxidative stress following environmental enrichment in mice with Alzheimer-like pathology. Brain Pathol. (2010) 20(1):166-75. doi: 10.1111/j.1750-3639.2008.00257.x

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Liew AKY, Teo CH, Soga T. The Molecular Effects of Environmental Enrichment on Alzheimer's Disease. Mol Neurobiol. (2022) 59(12):7095-118.36083518

PubMed Abstract | Google Scholar

15. Renoir T, Pang TY, Mo C, Chan G, Chevarin C, Lanfumey L, et al. Differential effects of early environmental enrichment on emotionality related behaviours in Huntington's disease transgenic mice. J Physiol. (2013) 591(1):41-55. doi: 10.1113/jphysiol.2012.239798

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Sztainberg Y, Kuperman Y, Tsoory M, Lebow M, Chen A. The anxiolytic effect of environmental enrichment is mediated via amygdalar CRF receptor type 1. Mol Psychiatry. (2010) 15(9):905-17. doi: 10.1038/mp.2009.151

PubMed Abstract | CrossRef Full Text | Google Scholar

17. van Praag H, Kempermann G, Gage FH. Neural consequences of environmental enrichment. Nat Rev Neurosci. (2000) 1(3):191-8. doi: 10.1038/35044558

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Janssen H, Ada L, Karayanidis F, Drysdale K, McElduff P, Pollack M, et al. Translating the use of an enriched environment poststroke from bench to bedside: study design and protocol used to test the feasibility of environmental enrichment on stroke patients in rehabilitation. Int J Stroke. (2012) 7(6):521-6.22264219

PubMed Abstract | Google Scholar

19. Rosbergen IC, Grimley RS, Hayward KS, Walker KC, Rowley D, Campbell AM, et al. The effect of an enriched environment on activity levels in people with stroke in an acute stroke unit: protocol for a before-after pilot study. Pilot Feasibility Stud. (2016) 2:36.27965854

PubMed Abstract | Google Scholar

20. Rosbergen IC, Grimley RS, Hayward KS, Walker KC, Rowley D, Campbell AM, et al. Embedding an enriched environment in an acute stroke unit increases activity in people with stroke: a controlled before-after pilot study. Clin Rehabil. (2017) 31(11):1516-28.28459184

PubMed Abstract | Google Scholar

21. Rosbergen ICM, Brauer SG, Fitzhenry S, Grimley RS, Hayward KS. Qualitative investigation of the perceptions and experiences of nursing and allied health professionals involved in the implementation of an enriched environment in an Australian acute stroke unit. BMJ Open. (2017) 7(12):e018226.29273658

PubMed Abstract | Google Scholar

22. Flores-Ramos M, Yoldi-Negrete M, Guiza-Zayas R, Ramirez-Rodriguez GB, Montes-Castrejon A, Fresan A. An Indicator of environmental enrichment to measure physical, social and cognitive activities in human daily life. BMC Psychiatry. (2022) 22(1):295.35468768

PubMed Abstract | Google Scholar

23. Gimenez-Llort L, Mate I, Manassra R, Vida C, De la Fuente M. Peripheral immune system and neuroimmune communication impairment in a mouse model of Alzheimer's disease. Ann N Y Acad Sci. (2012) 1262:74-84.22823438

PubMed Abstract | Google Scholar

24. Singhal G, Jaehne EJ, Corrigan F, Baune BT. Cellular and molecular mechanisms of immunomodulation in the brain through environmental enrichment. Front Cell Neurosci. (2014) 8:97.24772064

PubMed Abstract | Google Scholar

25. Konkle AT KA, Baker SL, Stewart A, Bielajew C. Environmental-enrichment-related variations in behavioral, biochemical, and physiologic responses of Sprague-Dawley and long Evans rats. J Am Assoc Lab Anim Sci. (2010) 49:427.20819388

PubMed Abstract | Google Scholar

26. Le Fevre M MJ, Kolt GS. Eustress, distress, and interpretation in occupational stress. Journal Managerial Psycholog. (2003) 18(7):726-44.

Google Scholar

27. Kilpatrick LA, Suyenobu BY, Smith SR, Bueller JA, Goodman T, Creswell JD, et al. Impact of Mindfulness-Based Stress Reduction training on intrinsic brain connectivity. Neuroimage. (2011) 56(1):290-8.21334442

PubMed Abstract | Google Scholar

28. BN S. The importance of novelty in psychotherapy.: Academic Press; (2006.

29. Brasil DL, Montagna E, Trevisan CM, La Rosa VL, Lagana AS, Barbosa CP, et al. Psychological stress levels in women with endometriosis: systematic review and meta-analysis of observational studies. Minerva Med. (2020) 111(1):90-102.31755674

PubMed Abstract | Google Scholar

30. Lazzeri L, Orlandini C, Vannuccini S, Pinzauti S, Tosti C, Zupi E, et al. Endometriosis and perceived stress: impact of surgical and medical treatment. Gynecol Obstet Invest. (2015) 79(4):229-33.25591624

PubMed Abstract | Google Scholar

31. Missmer SA, Tu FF, Agarwal SK, Chapron C, Soliman AM, Chiuve S, et al. Impact of Endometriosis on Life-Course Potential: A Narrative Review. Int J Gen Med. (2021) 14:9-25.33442286

PubMed Abstract | Google Scholar

32. Creekmore AL, Hong S, Zhu S, Xue J, Wiley JW. Chronic stress-associated visceral hyperalgesia correlates with severity of intestinal barrier dysfunction. Pain. (2018) 159(9):1777-89.29912860

PubMed Abstract | Google Scholar

33. Crettaz B, Marziniak M, Willeke P, Young P, Hellhammer D, Stumpf A, et al. Stress-induced allodynia--evidence of increased pain sensitivity in healthy humans and patients with chronic pain after experimentally induced psychosocial stress. PLoS One. (2013) 8(8):e69460.23950894

PubMed Abstract | Google Scholar

34. Cuevas M, Cruz ML, Ramirez AE, Flores I, Thompson KJ, Bayona M, et al. Stress During Development of Experimental Endometriosis Influences Nerve Growth and Disease Progression. Reprod Sci. (2018) 25(3):347-57.29108503

PubMed Abstract | Google Scholar

35. Cuevas M, Flores I, Thompson KJ, Ramos-Ortolaza DL, Torres-Reveron A, Appleyard CB. Stress exacerbates endometriosis manifestations and inflammatory parameters in an animal model. Reprod Sci. (2012) 19(8):851-62.22527982

PubMed Abstract | Google Scholar

36. Lima AP, Moura MD, Rosa e Silva AA. Prolactin and cortisol levels in women with endometriosis. Braz J Med Biol Res. (2006) 39(8):1121-7.16906287

PubMed Abstract | Google Scholar

37. Petrelluzzi KF, Garcia MC, Petta CA, Grassi-Kassisse DM, Spadari-Bratfisch RC. Salivary cortisol concentrations, stress and quality of life in women with endometriosis and chronic pelvic pain. Stress. (2008) 11(5):390-7.18800310

PubMed Abstract | Google Scholar

38. Quinones M, Urrutia R, Torres-Reveron A, Vincent K, Flores I. Anxiety, coping skills and hypothalamus-pituitary-adrenal (HPA) axis in patients with endometriosis. J Reprod Biol Health. (2015) 3.26900480

Google Scholar

39. Hernandez S, Cruz ML, Seguinot II, Torres-Reveron A, Appleyard CB. Impact of Psychological Stress on Pain Perception in an Animal Model of Endometriosis. Reprod Sci. (2017:1933719116687655.

Google Scholar

40. Appleyard CB, Cruz ML, Hernandez S, Thompson KJ, Bayona M, Flores I. Stress management affects outcomes in the pathophysiology of an endometriosis model. Reprod Sci. (2015) 22(4):431-41.25015902

PubMed Abstract | Google Scholar

41. Appleyard CB, Flores I, Torres-Reveron A. The Link Between Stress and Endometriosis: from Animal Models to the Clinical Scenario. Reprod Sci. (2020) 27(9):1675-86.32542543

PubMed Abstract | Google Scholar

42. Torres-Reveron A, Rivera LL, Flores I, Appleyard CB. Environmental Manipulations as an Effective Alternative Treatment to Reduce Endometriosis Progression. Reprod Sci. (2018) 25(9):1336-48.29137551

PubMed Abstract | Google Scholar

43. Czajkowski SM, Powell LH, Adler N, Naar-King S, Reynolds KD, Hunter CM, et al. From ideas to efficacy: The ORBIT model for developing behavioral treatments for chronic diseases. Health Psychol. (2015) 34(10):971-82.25642841

PubMed Abstract | Google Scholar

44. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. (2009) 6(7):e1000100.19621070

PubMed Abstract | Google Scholar

45. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. (2015) 349:g7647.

Google Scholar

46. Goncalves AV, Barros NF, Bahamondes L. The Practice of Hatha Yoga for the Treatment of Pain Associated with Endometriosis. J Altern Complement Med. (2017) 23(1):45-52.27869485

PubMed Abstract | Google Scholar

47. Shoebotham A, Coulson NS. Therapeutic Affordances of Online Support Group Use in Women With Endometriosis. J Med Internet Res. (2016) 18(5):e109.27160641

PubMed Abstract | Google Scholar

48. Yang NY, Kim SD. Effects of a Yoga Program on Menstrual Cramps and Menstrual Distress in Undergraduate Students with Primary Dysmenorrhea: A Single-Blind, Randomized Controlled Trial. J Altern Complement Med. (2016) 22(9):732-8.27315239

PubMed Abstract | Google Scholar

49. Goncalves AV, Makuch MY, Setubal MS, Barros NF, Bahamondes L. A Qualitative Study on the Practice of Yoga for Women with Pain-Associated Endometriosis. J Altern Complement Med. (2016) 22(12):977-82.27552065

PubMed Abstract | Google Scholar

50. Twal WO, Wahlquist AE, Balasubramanian S. Yogic breathing when compared to attention control reduces the levels of pro-inflammatory biomarkers in saliva: a pilot randomized controlled trial. BMC Complement Altern Med. (2016) 16:294.27538513

PubMed Abstract | Google Scholar

51. Sadeghi Aval Shahr H, Saadat M, Kheirkhah M, Saadat E. The effect of self-aromatherapy massage of the abdomen on the primary dysmenorrhoea. J Obstet Gynaecol. (2015) 35(4):382-5.25254570

PubMed Abstract | Google Scholar

52. Sin WM, Chow KM. Effect of Music Therapy on Postoperative Pain Management in Gynecological Patients: A Literature Review. Pain Manag Nurs. (2015) 16(6):978-87.26697822

PubMed Abstract | Google Scholar

53. Czamanski-Cohen JSO, Huss E, Ifergane A, Niego L, Cwikel J. CB-ART-The use of a hybrid cognitive behavioral and art based protocol for treating pain and symptoms accompanying coping with chronic illness. The Arts in Psychotherapy. (2014) 41(4):320-8.

Google Scholar

54. Berto R. The role of nature in coping with psycho-physiological stress: a literature review on restorativeness. Behav Sci (Basel). (2014) 4(4):394-409.25431444

PubMed Abstract | Google Scholar

55. Ou MC, Hsu TF, Lai AC, Lin YT, Lin CC. Pain relief assessment by aromatic essential oil massage on outpatients with primary dysmenorrhea: a randomized, double-blind clinical trial. J Obstet Gynaecol Res. (2012) 38(5):817-22.22435409

PubMed Abstract | Google Scholar

56. Baptista AS, Villela AL, Jones A, Natour J. Effectiveness of dance in patients with fibromyalgia: a randomized, single-blind, controlled study. Clin Exp Rheumatol. (2012) 30(6 Suppl 74):18-23.23020850

PubMed Abstract | Google Scholar

57. Hughes EG, da Silva AM. A pilot study assessing art therapy as a mental health intervention for subfertile women. Hum Reprod. (2011) 26(3):611-5.21247921

PubMed Abstract | Google Scholar

58. Bojner Horwitz EKJ, Anderberg UM. Theater for, by and with fibromyalgia patients - Evaluation of emotional expression using video interpretation. The Arts in Psychotherapy. (2010) 37(1):13-9.

Google Scholar

59. Moreira MF, Gamboa OL, Pinho Oliveira MA. A single-blind, randomized, pilot study of a brief mindfulness-based intervention for the endometriosis-related pain management. Eur J Pain. (2022) 26(5):1147-62.

Google Scholar

60. Vitonis AF, Vincent K, Rahmioglu N, Fassbender A, Buck Louis GM, Hummelshoj L, et al. World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: II. Clinical and covariate phenotype data collection in endometriosis research. Fertil Steril. (2014) 102(5):1223-32.25256930

PubMed Abstract | Google Scholar

61. Braun V, Clarke V. One size fits all? What counts as quality practice in (reflexive) thematic analysis? Qualitative Research in Psychology (2021) 18(3).

Google Scholar

62. Yin B, Jiang H, Liu X, Guo SW. Enriched Environment Decelerates the Development of Endometriosis in Mouse. Reprod Sci. (2020) 27(7):1423-35.32318984

PubMed Abstract | Google Scholar

63. Segura-Jimenez V, Romero-Zurita A, Carbonell-Baeza A, Aparicio VA, Ruiz JR, Delgado-Fernandez M. Effectiveness of Tai-Chi for decreasing acute pain in fibromyalgia patients. Int J Sports Med. (2014) 35(5):418-23.24203799

PubMed Abstract | Google Scholar

64. Shariff F, Carter J, Dow C, Polley M, Salinas M, Ridge D. Mind and body management strategies for chronic pain and rheumatoid arthritis. Qual Health Res. (2009) 19(8):1037-49.19638598

PubMed Abstract | Google Scholar

65. Wang C. Tai Chi improves pain and functional status in adults with rheumatoid arthritis: results of a pilot single-blinded randomized controlled trial. Med Sport Sci. (2008) 52:218-29.18487901

PubMed Abstract | Google Scholar

66. Subramaniam V, Stewart MW, Smith JF. The development and impact of a chronic pain support group: a qualitative and quantitative study. J Pain Symptom Manage. (1999) 17(5):376-83.10355217

PubMed Abstract | Google Scholar

67. Bushnell MC, Case LK, Ceko M, Cotton VA, Gracely JL, Low LA, et al. Effect of environment on the long-term consequences of chronic pain. Pain. (2015) 156 Suppl 1:S42-9.25789436

PubMed Abstract | Google Scholar

68. Hsu YC, Tsai SF, Yu L, Chuang JI, Wu FS, Jen CJ, et al. Long-term moderate exercise accelerates the recovery of stress-evoked cardiovascular responses. Stress. (2016) 19(1):125-32.26473638

PubMed Abstract | Google Scholar

69. Goyal M, Singh S, Sibinga EM, Gould NF, Rowland-Seymour A, Sharma R, et al. Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Intern Med. (2014) 174(3):357-68.24395196

PubMed Abstract | Google Scholar

70. Berga SL, Loucks TL. Use of cognitive behavior therapy for functional hypothalamic amenorrhea. Ann N Y Acad Sci. (2006) 1092:114-29.17308138

PubMed Abstract | Google Scholar

71. Friggi Sebe Petrelluzzi KGM, Petta CA, Ribeiro DA, de Oliveira Monteiro NR, Céspedes IC, Spadari RC. Physical therapy and psychological intervention normalize cortisol levels and improve vitality in women with endometriosis. J Psychosom Obstet Gynaecol. (2012) 33(4):191-8.23094607

PubMed Abstract | Google Scholar

72. Armour M, Cave AE, Schabrun SM, Steiner GZ, Zhu X, Song J, et al. Manual Acupuncture Plus Usual Care Versus Usual Care Alone in the Treatment of Endometriosis-Related Chronic Pelvic Pain: A Randomized Controlled Feasibility Study. J Altern Complement Med. (2021) 27(10):841-9.34161143

PubMed Abstract | Google Scholar

73. Rubi-Klein K, Kucera-Sliutz E, Nissel H, Bijak M, Stockenhuber D, Fink M, et al. Is acupuncture in addition to conventional medicine effective as pain treatment for endometriosis? A randomised controlled cross-over trial. Eur J Obstet Gynecol Reprod Biol. (2010) 153(1):90-3.

PubMed Abstract | Google Scholar

74. Gregoire CA, Bonenfant D, Le Nguyen A, Aumont A, Fernandes KJ. Untangling the influences of voluntary running, environmental complexity, social housing and stress on adult hippocampal neurogenesis. PLoS One. (2014) 9(1):e86237.24465980

PubMed Abstract | Google Scholar